首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Immunooncology and technology

缩写:

ISSN:2590-0188

e-ISSN:

IF/分区:0.0/

文章目录 更多期刊信息

共收录本刊相关文章索引110
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
L E Stopfer,A D D&#x;Souza,F M White L E Stopfer
Quantitative mass-spectrometry-based methods to perform relative and absolute quantification of peptides in the immunopeptidome are growing in popularity as researchers aim to measure the dynamic nature of the peptide major histocompatibili...
[This corrects the article DOI: 10.1016/j.iotech.2019.11.003.][This corrects the article DOI: 10.1016/j.iotech.2021.100034.][This corrects the article DOI: 10.1016/j.iotech.2020.03.001.][This corrects the article DOI: 10.1016/j.iotech.2019....
D W Vredevoogd,G Apriamashvili,D S Peeper D W Vredevoogd
Functional genetic screens by CRISPR-Cas9 allow for the unbiased discovery of proteins causally involved in complex biological processes. In recent years, this approach has been used by multiple laboratories to uncover a range of tumor cell...
Z Bodalal,I Wamelink,S Trebeschi et al. Z Bodalal et al.
With the ongoing advances in imaging techniques, increasing volumes of anatomical and functional data are being generated as part of the routine clinical workflow. This surge of available imaging data coincides with increasing research in q...
Vylyny Chat,Robert Ferguson,Tomas Kirchhoff Vylyny Chat
In immuno-oncology (IO), the baseline host factors attract significant clinical interest as promising predictive biomarker candidates. Growing evidence from experimental or population-based studies suggests that the host genetic factors con...
Qian Chen,Tianyuan Ci,Zhen Gu Qian Chen
Background: Surgery remains the first option to treat most solid tumors. However, despite the development of surgical techniques, the elimination of tumor recurrence after surgery remains a challenge. ...
R M Koldej,D S Ritchie R M Koldej
Background: To date, studies into the bone marrow (BM) immune microenvironment have been limited due to reliance on the analysis of BM aspirates in which the microenvironmental context is lost. GeoMX™ digital spatial pro...
E A Lim,C G Drake,A Mintz E A Lim
Immunotherapy has changed the treatment landscape for many cancers; however, not all patients treated have a favorable response and others can develop immune-related adverse events. A method to predict the treatment response to immunotherap...